TNF and neoplasm: It is possible that the limited penetration of infliximab into the tumour tissue resulted in active transmembrane TNF-α remaining deep in the tissue, which continued to signal in a juxtacrine manner and supported tumour growth, even when infliximab had reduced the concentration of circulating sTNF-α.